课题基金 / 基金详情

The regulation mechanism of degradation of p35 CDK5 activation subunit in neurons

The regulation mechanism of degradation of p35 CDK5 activation subunit in neurons
神经元p35 CDK5激活亚基降解的调控机制
批准号:
12680700
负责人:
HISANAGA Shin-ichi
金额:
$2.43万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

HISANAGA Shin-ichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cdk5, a cdc2-related kinase expressed in postmitotic neurons, is activated by association with a brain-specific activator, p35. It has been suggested that the conversion of p35 to p25 by the protease calpain is involved in neuronal cell death. On the other hand, p35 protein is rapidly turned over via proteasomal degradation in living neurons. Here, we show that the phosphorylation of p35 is involved in the control of its proteolytic degradation, and that the phosphorylation status of p35 changes in a developmental manner. The phosphorylated form of p35 is resistant to cleavage by calpain and is more susceptible to proteasomal degradation. The unphosphorylated form of p35 is more resistant to proteasomal degradation but is more susceptible to calpain-dependent cleavage to produce p25. Autophosphorylation of p35 by Cdk5 suppresses the cleavage to p25 by calpain, whereas autophosphorylation facilitates the proteasomal degradation of p35. A phosphorylated form of p35 is more prevalent in the fetal brain, whereas the unphosphorylated form of p35 occurs in the adult brain. These results suggest that the autophosphorylation of p35 serves as a protective mechanism that suppresses the generation of p25 in developing brains.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
Uchida et al.: "The neurofilament of Klotho, the mutant mouse prepaturely displaying symptoms resembling human aging"J.Neurosci.Res. 64. 364-370 (2001)
Uchida 等人:“Klotho 的神经丝,突变小鼠预先表现出类似于人类衰老的症状”J.Neurosci.Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Taniguchi, S. et al.: "Calpain-mediated degradation of p35 to p25 postmortem human and rat brains"FEBS letter. 489. 46-50 (2001)
Taniguchi, S. 等人:“钙蛋白酶介导的 p35 至 p25 死后人类和大鼠大脑的降解”FEBS 信件。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Bibb et al.: "Phosphorylation of protein phosphatase inhibitore-I by Cdk5"J.Biol.Chem.. 276. 14490-14497 (2001)
Bibb 等人:“Cdk5 对蛋白磷酸酶抑制剂-I 的磷酸化”J.Biol.Chem.. 276. 14490-14497 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tokuda, H. et al.: "BDNF-induced phosphorylation of neurofilament-H subunit in primary culture of rat cortical neurons"J. Cell Sci.. 113. 1059-1068 (2000)
Tokuda, H. 等人:“大鼠皮质神经元原代培养物中 BDNF 诱导的神经丝 H 亚基磷酸化”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Regulation of endosome formation and recycling by Cdk5/p35 in neurons
    • 批准号:
      20370047
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2008
    • 负责人:
      HISANAGA Shin-ichi
    • 依托单位:
    Regulation of Cdk5 activity and function in neurons
    • 批准号:
      17300119
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.65万
    • 财政年份:
      2005
    • 负责人:
      HISANAGA Shin-ichi
    • 依托单位:
    The novel function of cyclin-dependent kinase 5, a role in long term potentiation
    • 批准号:
      14580703
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2002
    • 负责人:
      HISANAGA Shin-ichi
    • 依托单位:
    Activation or inactivation mechanism of brain cdc2-like kinase, cdk5
    • 批准号:
      09480191
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      1997
    • 负责人:
      HISANAGA Shin-ichi
    • 依托单位:
    国内基金
    海外基金
    基于力学微环境探讨ERK/CDK5/P-MIEF1轴阻滞AECII分化在肺纤维化中的作用及机制研究
    USP4/Fbxw7通过稳定CDK5促进线粒体裂变进而通过重塑谷氨酰胺代谢介导胃癌曲妥珠单抗耐药的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      黎晖
    • 依托单位:
    圣草酚靶向结合PSA稳定CDK5激活Nrf2信号抑制铁死亡的抗AD机制 研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      李文军
    • 依托单位:
    基于 CDK5/P35 信号通路探究脊髓水平去甲肾 上腺素能神经元调控慢性神经病理性疼痛潜 在的临床应用机制研究
    • 批准号:
      HZY24H090005
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      沈悦
    • 依托单位: